OUR STORY
Bonescreen offers a novel, AI-based technology for non-invasive extraction of biomarkers from existing medical images to assist radiologists and clinicians in evaluating bone health.
products
SpineQ assists
clinicians in diagnosing*
Products
SpineQ assists clinicians in diagnosing*
Bonescreen spineQ assists clinicians in diagnosing osteoporosis from almost any existing routine CT containing the spine. spineQ provides a comprehensive spine report, including a level-wise annotation, a calibrated, reproducible bone mineral density measurement and osteoporotic fracture identification. It is designed to shorten reporting times and improve report quality by highlighting abnormal findings relevant for osteoporosis that are frequently overlooked.
SpineR facilitates your spine processing*
Bonescreen spineR is easily integrated in many environments as the backbone of spine processing. In CT scans, SpineR segments and labels all vertebrae, identifies subregions and special points of interest, like commonly needed in automated surgery planning, PACS-overlays, finite element modelling, 3D printing and more. Bonescreen spineR outperforms current state of the art methods for spine segmentation in a computationally efficient way without the need for a GPU. Bonescreen readily identifies transitional vertebrae and all enumeration anomalies.
users
Bonescreen fits your needs
Optimised for your working environment
Radiologists
Empowering radiologists with precise, quantitative insights into bone diseases, such as osteoporosis, for more informed diagnoses.
PACS
Seamlessly integrating context information and anatomical guidance, enhancing the efficiency and completeness of patient records.
Research
Enabling bone researchers with advanced tools for precise segmentation and landmark detection, accelerating their research efforts.
Clinicians
Providing clinicians with a quick, at-a-glance way to identify patients at risk, enhancing patient care and decision-making.
Surgeons
Intraoperative provision of level specific quantitative information on bone quality to surgeons in real time.
scientific studies
Bonescreen is backed by peer-reviewed research
Our Partners
Financial & scientific partners
about us
Bonescreen was founded in 2022 and is headquartered in Munich.
Collectively, we have 25 years of experience in radiology and 15 of experience in software engineering and machine learning.
Why do we need
biomarker extraction?
The doubling of the population older than 60 years during the next three decades will bring an explosion of bone-health-related conditions. Among these, Osteoporosis represents the most common bone disease in humans.
EFFECTIVE SCREENING
Osteoporosis is a disease that can be treated effectively, if diagnosed early. However, effective screening programs are currently missing. This is what Bonescreen aims to improve with our AI-based opportunistic screening software.
EARLY DIAGNOSIS
In a similar way, we are working on a solution to detect malignant bone lesions much earlier and more accurate compared to the current standard. All these patients may highly benefit from an earlier and more accurate diagnosis.
Preventive healthcare remains an underserved market
On average, European countries invest circa 3-4% of their total healthcare spend in preventive measures. The remaining 97% of costs goes to treating diseases.
REDUCED COST
This is too low, claims the OECD. Estimates imply that healthcare costs could be reduced by 30% if more preventive action were taken. In light of the €55bn the EU spends every year on the treatment of osteoporotic fractures, this implies cost savings of €15bn.
PREVERTION
Let alone the prevented loss of quality in life of the more than 4 million European patients who suffer an osteoporotic fracture each year. At Bonescreen, we build prevention. An impact tool to provide millions of Europeans access to preventive measures.
NEWS